Vital Pulp Treatment in Primary Teeth
- Conditions
- Vital Pulp TherapiesIndirect Pulp CapPulpotomy
- Interventions
- Drug: BiodentinDevice: VitrebondDrug: Mineral Trioxide Aggregate
- Registration Number
- NCT02298504
- Lead Sponsor
- University of Maryland, Baltimore
- Brief Summary
In primary teeth, decay that is near the pulp (tooth nerve)is treated with either a pulpotomy or indirect pulp treatment if the tooth is not going to be extracted A pulpotomy involves removing the top 1/2 of the pulp, placing a medication/material on the pulp, covering the remaining pulp with a cement, and the restoring the tooth. The purpose of this pilot study is to gain preliminary information regarding the success of Biodentine, MTA, and IPT in the treatment of deep decay in children's primary molars.
- Detailed Description
Pediatric patients having deep decay in primary molars seen at UMMC, UMSOD, and University of Maryland Rehabilitation and Orthopaedic Institute, will be included in the sample. Teeth with deep caries, \>50% into dentin, will be randomly assigned using a table of random numbers to the three treatment groups:
Group 1 pulpotomy with MTA, Group 2 pulpotomy with Biodentine, Group 3 indirect pulp treatment. Treatment will be performed by board certified pediatric dentists or they will directly supervise pediatric dental residents at each site as part of their regular protocol for treating deep caries.
Radiographs will be taken as prescribed in the Guideline for taking Radiographs in Children by the American Academy of Pediatric Dentistry.
Twice yearly clinical examinations will be performed by the treating dentists or pediatric dental residents to check for any soft tissue pathology such as abscess or mobility of treated tooth/teeth. If treatment success/failure consensus between the blinded dentists is not reached, a third dentist will be consulted.
The success/failure data will be entered onto spreadsheets and examined statistically using statistical software.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 76
- Pediatric patients with deep dental decay in primary molars
- Teeth with signs and symptoms of reversible pulpitis
- Teeth with clinical symptoms of irriversible pulpitis or pulp necrosis or acute dental infection
- Children with systemic illness that contraindicated vital pulp treatment such a sickle cell disease
- Teeth that are not restorable
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Biodentin pulpotomy Biodentin Biodentin pulpotomy will be performed for this group Indirect pulp cap Vitrebond IDP will be performed for this group MTA pulpotomy Mineral Trioxide Aggregate MTA pulpotomy will be performed for this group
- Primary Outcome Measures
Name Time Method Clinical success after pulpotomy 3 years No signs of abscess or any swelling related to the tooth, no signs of fistula or other pathology, no signs of pathologic mobility, no post-operative pain, no pain on palpation or percussion of the tooth
Clinical success after indirect pulp cap 3 years No signs of abscess or any swelling related to the tooth, no signs of fistula or other pathology, no signs of pathologic mobility, no post-operative pain, no pain on palpation or percussion of the tooth
Radiographic success after pulpotomy 3 years No signs of root resorption (internal or external), no signs of furcation involvement or periapical radiolucency, no signs of loss of lamina dura, presence of normal appearance of periodontal ligament space
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Maryland School of Dentistry
🇺🇸Baltimore, Maryland, United States